@prefix jvr: . @prefix skos: . @prefix mesh: . @prefix dc: . @prefix xsd: . @prefix owl: . jvr:-BT300B3G-Q skos:prefLabel "cerebrospinal fluid (Qualifier)"@en, "liquide cérébrospinal (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WX56JBDJ-S skos:prefLabel "Région variable d'immunoglobuline"@fr, "Immunoglobulin Variable Region"@en ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-X5LHS72R-2 . jvr:-L6C0XPHT-4 skos:prefLabel "métabolisme (Qualificatif)"@fr, "metabolism (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-XV06LPML-W skos:prefLabel "urine (Qualifier)"@en, "urine (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-G7KXQWSR-5 skos:prefLabel "biosynthèse (Qualificatif)"@fr, "biosynthesis (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-Z9TSGBXH-4 skos:prefLabel "génétique (Qualificatif)"@fr, "genetics (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-Q3979798-W skos:prefLabel "analysis (Qualifier)"@en, "analyse (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-H7K65Q8S-Z skos:prefLabel "radiation effects (Qualifier)"@en, "effets des radiations (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-TJHVZCRZ-0 skos:prefLabel "administration et posologie (Qualificatif)"@fr, "administration & dosage (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-G30ZJ446-J skos:prefLabel "toxicity (Qualifier)"@en, "toxicité (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NFTHND7Q-8 skos:prefLabel "intoxication (Qualificatif)"@fr, "poisoning (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-FWD2BGQ0-9 skos:prefLabel "usage thérapeutique (Qualificatif)"@fr, "therapeutic use (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-S0CS1X5R-5 skos:prefLabel "immunology (Qualifier)"@en, "immunologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-HQRFT0C6-B skos:prefLabel "isolement et purification (Qualificatif)"@fr, "isolation & purification (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-T2TS0S41-N skos:prefLabel "ultrastructure (Qualifier)"@en, "ultrastructure (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NB0XHT3S-N skos:prefLabel "adverse effects (Qualifier)"@en, "effets indésirables (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-W6SQV79N-S skos:prefLabel "classification (Qualifier)"@en, "classification (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-CB30NGKB-3 skos:prefLabel "economics (Qualifier)"@en, "économie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr: a skos:ConceptScheme . jvr:-SBNWSM1T-R skos:prefLabel "history (Qualifier)"@en, "histoire (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-XG3R27ZM-S skos:prefLabel "Receptors, Antigen, T-Cell"@en, "Récepteurs aux antigènes des cellules T"@fr ; a mesh:Descriptor, skos:Concept ; skos:narrower jvr:-X5LHS72R-2 . jvr:-D0F21513-5 skos:prefLabel "chemistry (Qualifier)"@en, "composition chimique (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-X5LHS72R-2 skos:altLabel "Complementarity-Determining Region"@en, "Régions CDR"@fr, "Régions hypervariables"@fr, "Hypervariable Region, Immunoglobulin"@en, "CDR (Complementarity Determining Region)"@fr, "Hypervariable Regions, Immunoglobulin"@en, "Complementarity Determining Region"@en, "Régions déterminantes de la complémentarité"@fr, "Séquences CDR"@fr ; skos:hiddenLabel "Région-1 déterminant la complémentarité"@fr, "Région-III déterminant la complémentarité"@fr, "Complementarity Determining Region 2"@en, "Complementarity Determining Region I"@en, "Région-II déterminant la complémentarité"@fr, "Complementarity Determining Region 1"@en, "Complementarity-Determining Region 3"@en, "Third Complementarity-Determining Region"@en, "Complementarity Determining Region III"@en, "CDR3 (Complementarity Determining Region 3)"@fr, "Région-2 déterminant la complémentarité"@fr, "Séquence CDR2"@fr, "CDR2 (Complementarity Determining Region 2)"@fr, "Région-I déterminant la complémentarité"@fr, "Complementarity Determining Region II"@en, "Région CDR3"@fr, "Région CDR1"@fr, "CDR1 (Complementatity Determining Region 1)"@fr, "Région-3 déterminant la complémentarité"@fr, "Séquence CDR1"@fr, "Complementarity Determining Region 3"@en, "Région CDR2"@fr, "Séquence CDR3"@fr ; mesh:allowableQualifier jvr:-S0CS1X5R-5, jvr:-L6C0XPHT-4, jvr:-CB30NGKB-3, jvr:-N2WP45CN-V, jvr:-G7KXQWSR-5, jvr:-XV06LPML-W, jvr:-H7K65Q8S-Z, jvr:-Z9TSGBXH-4, jvr:-FWD2BGQ0-9, jvr:-SBNWSM1T-R, jvr:-G30ZJ446-J, jvr:-NB0XHT3S-N, jvr:-WZF2ZR3L-B, jvr:-W6SQV79N-S, jvr:-Q3979798-W, jvr:-T2TS0S41-N, jvr:-D0F21513-5, jvr:-TJHVZCRZ-0, jvr:-NHL3D2X0-S, jvr:-BT300B3G-Q, jvr:-HQRFT0C6-B, jvr:-NFTHND7Q-8, jvr:-NKM836P1-M ; dc:established "2001-01-01"^^xsd:date ; skos:broader jvr:-WX56JBDJ-S, jvr:-XG3R27ZM-S ; owl:sameAs ; skos:prefLabel "Régions déterminant la complémentarité"@fr, "Complementarity Determining Regions"@en ; a skos:Concept, mesh:Descriptor ; dc:created "2000-06-22"^^xsd:date ; skos:inScheme jvr: ; skos:definition "Three regions (CDR1; CDR2 and CDR3) of amino acid sequence in the IMMUNOGLOBULIN VARIABLE REGION that are highly divergent. Together the CDRs from the light and heavy immunoglobulin chains form a surface that is complementary to the antigen. These regions are also present in other members of the immunoglobulin superfamily, for example, T-cell receptors (RECEPTORS, ANTIGEN, T-CELL)."@en ; dc:modified "2011-06-24"^^xsd:date . jvr:-NHL3D2X0-S skos:prefLabel "sang (Qualificatif)"@fr, "blood (Qualifier)"@en ; a mesh:Qualifier, skos:Concept . jvr:-N2WP45CN-V skos:prefLabel "drug effects (Qualifier)"@en, "effets des médicaments et des substances chimiques (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-NKM836P1-M skos:prefLabel "pharmacology (Qualifier)"@en, "pharmacologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept . jvr:-WZF2ZR3L-B skos:prefLabel "physiology (Qualifier)"@en, "physiologie (Qualificatif)"@fr ; a mesh:Qualifier, skos:Concept .